# Genetic Variation in OCT1 and Response to Metformin

> **NCT00588172** · PHASE4 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00588172
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-06
- **Primary completion:** 2010-06
- **Final completion:** 2011-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding
- **Last updated:** 2010-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00588172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00588172, "Genetic Variation in OCT1 and Response to Metformin". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00588172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*